ARCA biopharma Inc. Common StockLive Price$2.09 USD
November 30, 2023, 11:20 pm UTC Add to Watchlist Create Price Alert
ARCA biopharma Inc. Common Stock (ABIO) - Live Price
ARCA biopharma Inc. Common Stock
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
Get ARCA biopharma Inc. Common Stock Price Change Alerts
Verdasi can notify you when ABIO goes up or down. Get a text message or email when ARCA biopharma Inc. Common Stock changes in price.Setup ABIO Price Alerts
How Many People are employed by ARCA biopharma, Inc.?
How are ARCA biopharma Inc. Common Stock divided?
Approximately 0.40% of ARCA biopharma Inc. Common Stock are owned by individual stakeholders. Mutual Funds actively invest in ARCA biopharma, Inc., controlling roughly 1.76% of all ARCA biopharma Inc. Common Stock.
- Individual Stakeholders: 0.40%
- Mutual Fund: 1.76%
- Other Institutions: 0.00%
How much is ARCA biopharma Inc. Common Stock stock worth?
ARCA biopharma Inc. Common Stock (ABIO) is worth $2.09 USD as of November 30, 2023, 11:20 pm UTC time.
View the interactive graph to see how much ARCA biopharma Inc. Common Stock has changed in the last hour or historically.
Keep learning about stocks:
When placing your trades, commissions can cut into your expected returns if you're not diligent about minimizing or eliminating trading fees entirely. Learn how!
Day trading has never been more accessible as a Canadian, with no minimum requirements, and the introduction of commission free trades. Learn how to day trade in Canada.